Cargando…
Toward interchangeable biologics
A biosimilar is designed to match the reference product – to be as close to the reference as the reference is to itself considering batch‐to‐batch variability and manufacturing changes over its lifetime.(1) Interchangeability will require additional data, however, the interchangeable biologic itself...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706804/ https://www.ncbi.nlm.nih.gov/pubmed/25670498 http://dx.doi.org/10.1002/cpt.39 |
_version_ | 1783445762147876864 |
---|---|
author | McCamish, M Pakulski, J Sattler, C Woollett, G |
author_facet | McCamish, M Pakulski, J Sattler, C Woollett, G |
author_sort | McCamish, M |
collection | PubMed |
description | A biosimilar is designed to match the reference product – to be as close to the reference as the reference is to itself considering batch‐to‐batch variability and manufacturing changes over its lifetime.(1) Interchangeability will require additional data, however, the interchangeable biologic itself will be the same as that approved for biosimilarity. |
format | Online Article Text |
id | pubmed-6706804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67068042019-08-28 Toward interchangeable biologics McCamish, M Pakulski, J Sattler, C Woollett, G Clin Pharmacol Ther Developments A biosimilar is designed to match the reference product – to be as close to the reference as the reference is to itself considering batch‐to‐batch variability and manufacturing changes over its lifetime.(1) Interchangeability will require additional data, however, the interchangeable biologic itself will be the same as that approved for biosimilarity. John Wiley and Sons Inc. 2015-01-21 2015-03 /pmc/articles/PMC6706804/ /pubmed/25670498 http://dx.doi.org/10.1002/cpt.39 Text en © 2015 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Developments McCamish, M Pakulski, J Sattler, C Woollett, G Toward interchangeable biologics |
title | Toward interchangeable biologics |
title_full | Toward interchangeable biologics |
title_fullStr | Toward interchangeable biologics |
title_full_unstemmed | Toward interchangeable biologics |
title_short | Toward interchangeable biologics |
title_sort | toward interchangeable biologics |
topic | Developments |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706804/ https://www.ncbi.nlm.nih.gov/pubmed/25670498 http://dx.doi.org/10.1002/cpt.39 |
work_keys_str_mv | AT mccamishm towardinterchangeablebiologics AT pakulskij towardinterchangeablebiologics AT sattlerc towardinterchangeablebiologics AT woollettg towardinterchangeablebiologics |